CreoSG Co.,Ltd. (KOSDAQ:040350)
4,270.00
+420.00 (10.91%)
At close: Sep 18, 2026
CreoSG Revenue
CreoSG had revenue of 3.18B KRW in the quarter ending June 30, 2026, with 15.90% growth. This brings the company's revenue in the last twelve months to 11.91B, up 33.49% year-over-year. In the year 2025, CreoSG had annual revenue of 10.86B with 33.15% growth.
Revenue (ttm)
11.91B
Revenue Growth
+33.49%
P/S Ratio
7.10
Revenue / Employee
290.54M
Employees
41
Market Cap
84.61B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.86B | 2.70B | 33.15% |
| Dec 31, 2024 | 8.16B | -1.60B | -16.39% |
| Dec 31, 2023 | 9.76B | -24.95M | -0.26% |
| Dec 31, 2022 | 9.78B | 1.15B | 13.27% |
| Dec 31, 2021 | 8.64B | -1.18B | -12.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| KAON Group | 505.71B |
| MDS Tech | 207.67B |
| Mercury | 126.32B |
| Amosense | 116.93B |
| CMG Pharmaceutical | 115.71B |
| Victek | 96.84B |
| meerecompany | 67.50B |
| INITECH | 35.08B |